130 related articles for article (PubMed ID: 18436522)
1. Efficient inhibition of cisplatin-resistant human ovarian cancer growth and prolonged survival by gene transferred vesicular stomatitis virus matrix protein in nude mice.
Zhong Q; Wen YJ; Yang HS; Luo H; Fu AF; Yang F; Chen LJ; Chen X; Qi XR; Lin HG; Wan Y; Chen XC; Wei YQ; Zhao X
Ann Oncol; 2008 Sep; 19(9):1584-91. PubMed ID: 18436522
[TBL] [Abstract][Full Text] [Related]
2. Efficient inhibition of intraperitoneal human ovarian cancer growth and prolonged survival by gene transfer of vesicular stomatitis virus matrix protein in nude mice.
Lin X; Chen X; Wei Y; Zhao J; Fan L; Wen Y; Wu H; Zhao X
Gynecol Oncol; 2007 Mar; 104(3):540-6. PubMed ID: 17112567
[TBL] [Abstract][Full Text] [Related]
3. Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer.
Luo H; Zhong Q; Chen LJ; Qi XR; Fu AF; Yang HS; Yang F; Lin HG; Wei YQ; Zhao X
J Cancer Res Clin Oncol; 2008 Sep; 134(9):937-45. PubMed ID: 18350317
[TBL] [Abstract][Full Text] [Related]
4. Efficient inhibition of ovarian cancer growth and prolonged survival by transfection with a novel pro-apoptotic gene, hPNAS-4, in a mouse model. In vivo and in vitro results.
Yang F; Li Z; Deng H; Yang H; Yan F; Qian Z; Chen L; Wei Y; Zhao X
Oncology; 2008; 75(3-4):137-44. PubMed ID: 18824876
[TBL] [Abstract][Full Text] [Related]
5. Matrix protein of vesicular stomatitis virus: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation.
Zhou Y; Wen F; Zhang P; Tang R; Li Q
Cancer Gene Ther; 2013 Mar; 20(3):178-85. PubMed ID: 23449478
[TBL] [Abstract][Full Text] [Related]
6. VEGF-D-enhanced lymph node metastasis of ovarian cancer is reversed by vesicular stomatitis virus matrix protein.
Qi X; Du L; Chen X; Chen L; Yi T; Chen X; Wen Y; Wei Y; Zhao X
Int J Oncol; 2016 Jul; 49(1):123-32. PubMed ID: 27211072
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis and inhibition of angiogenesis by PEGylated liposomal quercetin in both cisplatin-sensitive and cisplatin-resistant ovarian cancers.
Long Q; Xiel Y; Huang Y; Wu Q; Zhang H; Xiong S; Liu Y; Chen L; Wei Y; Zhao X; Gong C
J Biomed Nanotechnol; 2013 Jun; 9(6):965-75. PubMed ID: 23858960
[TBL] [Abstract][Full Text] [Related]
8. Millepachine showed novel antitumor effects in cisplatin-resistant human ovarian cancer through inhibiting drug efflux function of ATP-binding cassette transporters.
Wu W; Liu Y; Ye H; Li Z
Phytother Res; 2018 Dec; 32(12):2428-2435. PubMed ID: 30123958
[TBL] [Abstract][Full Text] [Related]
9. Vesicular stomatitis virus matrix protein (VSVMP) inhibits the cell growth and tumor angiogenesis in oral squamous cell carcinoma.
Zhou Y; Zhu X; Lu R; Dan H; Wang F; Wang J; Li J; Feng X; Wang H; Ji N; Zhou M; Zeng X; Jiang L; Chen Q
Oral Oncol; 2012 Feb; 48(2):110-6. PubMed ID: 22032899
[TBL] [Abstract][Full Text] [Related]
10. VSV-MP gene therapy strategy inhibits tumor growth in nude mice model of human lung adenocarcinoma.
Jing XM; Wen YJ; Shi W; Tang QQ; Li J; Chen XC
Cancer Gene Ther; 2012 Feb; 19(2):101-9. PubMed ID: 22052213
[TBL] [Abstract][Full Text] [Related]
11. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
Li D; Williams JI; Pietras RJ
Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
[TBL] [Abstract][Full Text] [Related]
12. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.
Wang Y; Mao H; Hao Q; Wang Y; Yang Y; Shen L; Huang S; Liu P
Regul Pept; 2012 Oct; 178(1-3):36-42. PubMed ID: 22759793
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
Lu J; Jin J; Xu WL
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy of adenovirus mediated CD ::upp/5-FC directed by GSTP1 promoter in cisplatin-resistant ovarian cancer.
Wang Z; Cai L; Wang H
Gynecol Oncol; 2005 Mar; 96(3):643-50. PubMed ID: 15721406
[TBL] [Abstract][Full Text] [Related]
15. Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels.
Bai Y; Gou M; Yi T; Yang L; Liu L; Lin X; Su D; Wei Y; Zhao X
Int J Med Sci; 2015; 12(5):397-406. PubMed ID: 26005374
[TBL] [Abstract][Full Text] [Related]
16. The activity profile of the hexacyclic camptothecin derivative DX-8951f in experimental human colon cancer and ovarian cancer.
van Hattum AH; Pinedo HM; Schlüper HM; Erkelens CA; Tohgo A; Boven E
Biochem Pharmacol; 2002 Oct; 64(8):1267-77. PubMed ID: 12234607
[TBL] [Abstract][Full Text] [Related]
17. TAT-OSBP-1-MKK6(E), a novel TAT-fusion protein with high selectivity for human ovarian cancer, exhibits anti-tumor activity.
Zhong J; Kang J; Wang X; Jiang W; Liao H; Yuan J
Med Oncol; 2015 Apr; 32(4):118. PubMed ID: 25782870
[TBL] [Abstract][Full Text] [Related]
18. [Influence of mifepristone on DNA repair genes and cisplatin sensitivity in human ovarian cancer drug-resistance cells].
Liu GY; Qu QX; Mi RR; Qi J
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):132-5. PubMed ID: 18683754
[TBL] [Abstract][Full Text] [Related]
19. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X
Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]